Kelly Constable

Kelly Constable

Director/Board Member at ProTA Therapeutics Pty Ltd.

Health Technology
Finance
Consumer Services

Profile

Ms. Kelly Constable is a Senior Advisor at Lumira Ventures and an Advisory Council at Medicines Australia.
She is on the Board of Directors at CERA Technologies Pty Ltd.
and ProTA Therapeutics Pty Ltd.
Ms. Constable was previously employed as a Venture partner by OneVentures Management Pty Ltd., a Board of Directors by Oculo Therapy LLC, a Chief strategy Officer by Omico Corp., a Board of Director & CEO by Genome One Pty Ltd., a Director of global marketing by Amgen AB, and a Senior product manager by Abbott Laboratories.
She received her undergraduate degree from the University of Tennessee.

Kelly Constable active positions

CompaniesPositionStart
Consultant / Advisor 2020-07-31
Director/Board Member 2020-01-31
Director/Board Member 2018-09-30
Director/Board Member -
All active positions of Kelly Constable

Former positions of Kelly Constable

CompaniesPositionEnd
Consultant / Advisor 2023-10-01
OMICO CORPORATION Corporate Officer/Principal 2019-12-01
Director/Board Member 2019-12-01
Genome One Pty Ltd. Chief Executive Officer 2018-08-30
Director/Board Member 2016-12-01
See the detail of Kelly Constable's experience

Training of Kelly Constable

University of Tennessee Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kelly Constable's experience

Connections

81

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ABBOTT LABORATORIES

Health Technology

OMICO CORPORATION

Finance

Private companies8

Health Technology

Health Technology

Finance

Genome One Pty Ltd.

Health Technology

Health Technology

Commercial Services

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Kelly Constable